<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03434925</url>
  </required_header>
  <id_info>
    <org_study_id>17-31909A</org_study_id>
    <nct_id>NCT03434925</nct_id>
  </id_info>
  <brief_title>Multi Parametric Test Predicting the Risk of Colorectal Neoplasia Recurrence</brief_title>
  <official_title>Development of a New Generation Multi Parametric Test for Prediction of Colorectal Neoplasia Recurrence</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Military University Hospital, Prague</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Military University Hospital, Prague</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This project is dedicated to identify the patients with possible higher risk of adenoma&#xD;
      recurrence who should have follow-up colonoscopy in yearly interval. As a result, it can lead&#xD;
      to optimizing the of follow-up colonoscopies intervals in real-world practice.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this project, 200 individuals (aged 18 - 75 years) with removed colorectal polyps larger&#xD;
      than 10 mm during colonoscopy performed based on all indication (including symptoms and&#xD;
      screening procedures) will be included. All procedures will be done with high quality&#xD;
      endoscopes (high definition, HD).&#xD;
&#xD;
      In all polyps, the advanced imaging techniques (such as chromoendoscopy and NBI) will be used&#xD;
      to determine parts of the polyp suspicious from high-grade dysplasia or cancer. The&#xD;
      therapeutic method will be decided by the size and macroscopic appearance of the polyp. In&#xD;
      case of flat, sessile polyps and LST lesions (laterally spreading tumors) EMR or ESD will be&#xD;
      performed. Pedunculated polyp will be removed by EPE. The goal is to achieve the en-bloc&#xD;
      resection. Pathologists (with presence of the endoscopist) will do the first step of&#xD;
      histopathology evaluation (cutting the polyp tissue). The aim is to perform the first cut in&#xD;
      the most advanced part of the polyp and high density cutting in this area. Standard&#xD;
      histopathology evaluation will proceed and will be followed by initial basic molecular&#xD;
      testing.&#xD;
&#xD;
      Subsequently, all patients will be observed by colonoscopy in one-year intervals with focus&#xD;
      on polyp recurrence. The group of high-risk patients will be selected with at least one of&#xD;
      these criteria: 1/ high grade dysplasia adenoma at index colonoscopy; 2/ high score of polyp&#xD;
      heterogenity at index colonoscopy; 3/ polyps recurrence at follow-up colonoscopy.&#xD;
&#xD;
      In a high-risk patients group the extensive somatic mutations profiling will be carried out&#xD;
      according to multitarget sequencing by NGS technologies (next generation sequencing). Same&#xD;
      testing will be done in randomly selected patients not included in the high-risk group, which&#xD;
      will be used as a control group for statistical evaluation.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date type="Actual">April 1, 2017</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">January 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Presence of genetic markers for local recurence after resection of colorectal neoplasia</measure>
    <time_frame>3 years</time_frame>
    <description>Measurement of gene mutations associated with local recurrence of advanced colorectal neoplasia after endoscopic resection.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Risk of polyp recurrence</measure>
    <time_frame>3 years</time_frame>
    <description>Measurement of the number of local recurrences after resection of advanced colorectal neoplasia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Topographic heterogenity of polyps</measure>
    <time_frame>3 years</time_frame>
    <description>Measurement of topographical characteristics of colorectal neoplasia (such as demography, histology, tumour genetic heterogeneity and presence of frequently mutated genes) associated with local recurrence.</description>
  </secondary_outcome>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Colon Cancer</condition>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>Multi-targeted next generation sequencing</intervention_name>
    <description>Study directed at finding molecular predictors of recurrent colorectal adenomas also taking into account the intrinsic level of heterogenity imprinted in the internal differences in molecular profiles</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Colorectal polyp larger than 10mm removed by colonoscopy therapeutic method (EPE, EMR,&#xD;
             ESD)&#xD;
&#xD;
          -  Signed informed consent with the study and with colonoscopy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  FAP, HNPCC and other hereditary CRC syndromes probands&#xD;
&#xD;
          -  Recent diagnostic, follow-up or preventive colonoscopy (FOBT-positive colonoscopy,&#xD;
             screening colonoscopy) in â‰¤ 3 years&#xD;
&#xD;
          -  Colonoscopy contraindication&#xD;
&#xD;
          -  Severe acute inflammatory bowel disease&#xD;
&#xD;
          -  Severe comorbidities; likely non-compliance of the patient&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stepan Suchanek, MD., Ph.D.</last_name>
    <role>Study Director</role>
    <affiliation>Military University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Stepan Suchanek, MD., Ph.D.</last_name>
    <phone>973208367</phone>
    <phone_ext>00420</phone_ext>
    <email>stepan.suchanek@uvn.cz</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Michal Voska, MD.</last_name>
    <phone>973203050</phone>
    <phone_ext>00420</phone_ext>
    <email>michal.voska@uvn.cz</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Military University Hospital</name>
      <address>
        <city>Prague</city>
        <zip>16902</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stepan Suchanek, MD., Ph.D.</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Czechia</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <study_first_submitted>January 31, 2018</study_first_submitted>
  <study_first_submitted_qc>February 14, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">February 15, 2018</study_first_posted>
  <last_update_submitted>February 14, 2018</last_update_submitted>
  <last_update_submitted_qc>February 14, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 15, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Military University Hospital, Prague</investigator_affiliation>
    <investigator_full_name>Stepan Suchanek, MD., Ph.D.</investigator_full_name>
    <investigator_title>MD., Ph.D.</investigator_title>
  </responsible_party>
  <keyword>colorectal neoplasia</keyword>
  <keyword>adenoma</keyword>
  <keyword>colonoscopy</keyword>
  <keyword>gene mutation</keyword>
  <keyword>follow-up</keyword>
  <keyword>recurrence</keyword>
  <keyword>multiparametric test</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasms</mesh_term>
    <mesh_term>Recurrence</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

